CVS Health to price dollar senior notes in three tranches

By Rebecca Melvin

New York, Aug. 12 – CVS Health Corp. is planning to price a three-part offering of dollar-denominated senior notes, according to a 424B3 filing with the Securities and Exchange Commission.

The notes are callable at par plus a make-whole premium.

Barclays, BofA Securities Inc., Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Mizuho Securities USA Inc. are the bookrunners of the transaction.

The proceeds of the new notes, together with cash on hand, will be used to repurchase notes in a tender offer. Any remaining proceeds will be used for general corporate purposes, including working capital and capital expenditures and repayment of debt.

The operator of retail pharmacies and pharmacy benefits manager is based in Woonsocket, R.I.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.